Indian markets closed with sharp losses on Thursday, with benchmark indices falling over 3 percent amid global risk-off ...

Chennai Super Kings suffer a setback as Nathan Ellis is ruled out of IPL 2026 with a hamstring injury. CEO Kasi Vishwanathan confirmed the news. The five-time champions are currently in the hunt for ...

Patent protections on semaglutide, developed by Novo Nordisk, will lapse on March 20, opening the door for domestic pharmaceutical companies to manufacture and sell their own versions of the drug.

New mysteries and puzzling cases await DI Humphrey Goodman and the team in Shipton Abbott.

Your Ozempic is set to get cheaper. But with over 50 brands of the same molecule hitting the market this year, which one will ...

The high-profile obesity and diabetes products Wegovy and Ozempic, from Danish healthcare company Novo Nordisk, will see a significant global development on Friday — as a patent on its active ...

With the patent for Semaglutide expiring on March 20, a number of Indian generic drug manufacturers are expected to enter the market and offer steep discounts ...

Pharma companies opt for partnerships to combine manufacturing scale with prescription reach as a ₹5,000 crore semaglutide ...

As Novo Nordisk’s patent expires on March 20, Sun Pharma, Dr Reddy’s, Zydus and Mankind enter the market after months of preparation, setting up a race for early share in one of the world’s most ...

Nathan Ellis, one of CSK's biggest bets to deliver in the death overs—especially after releasing Matheesha Pathirana—is also ...

Tapantosh Chakrabarty began running at 50, has battled multiple ailments and has raced on each continent in 70 total ...